Yahoo! Finance Search - Finance Home - Yahoo! - Help

Saturday, July 4 2009 3:12am ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Other News
View: Latest News | Top Stories
Friday, Jul 3, 2009
·Novo Nordisk wins Europe OK for diabetes drug
at MarketWatch - Fri 4:59 am ET
Thursday, Jul 2, 2009
·MoneyGram Int'l, Sepracor: Biggest Price Decliners (MGI, SEPR)
at The Wall Street Journal Online - Thu 4:53 pm ET
·Study of Sepracors Depression Drug Has Investors Gloomy
at Seeking Alpha - Thu 2:53 pm ET
·[external] Sepracor's depression candidate disappoints
at bizjournals.com - Thu 11:06 am ET
·Sepracor slides on trial failure and Lunesta halt
AP - Thu 9:40 am ET
·RothmanResearch.com Stock Review for VRX, ADI, CTL, SLM, UMC and FCX
Marketwire - Thu 8:15 am ET
·WallStSense.com Fundamental & Technical Coverage of ARNA, UCBH, OSCI, MVSN, CELG and AINV
Marketwire - Thu 7:39 am ET
·Acura, King get FDA response on Acurox
at MarketWatch - Thu 7:10 am ET
·Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
PR Newswire - Thu 7:00 am ET
Wednesday, Jul 1, 2009
·[video] Stock of the Day: NVO
at CNBC - Wed Jul 1
·[video] The Obama Trade: Healthcare
at CNBC - Wed Jul 1
·Sepracor Provides Update on Clinical Trials for SEP-225289 and LUNESTA® Pediatrics
Business Wire - Wed Jul 1
·Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
PR Newswire - Wed Jul 1
·Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gastrointestinal Injuries
Business Wire - Wed Jul 1
·FDA to review safety of Sanofi's Lantus
at MarketWatch - Wed Jul 1
·Mylan Expands into Biologics Space
Zacks.com - Wed Jul 1
·Investors Look Past Cephalon's Leukemia Setback
Zacks.com - Wed Jul 1
·Teva launches version of JNJ birth control pill
AP - Wed Jul 1
·AnalystChoice.com Brings You the Best Complimentary Research Report on FRX, CF, LOW, STT, AIZ and DPS
Marketwire - Wed Jul 1
·MiddleBrook Pharmaceuticals Secures $10 Million Revolving Line of Credit
Business Wire - Wed Jul 1
More Latest News...
Sponsor Results
Pharma Partnership
Pharmaceutical development partner. Learn why companies choose TEVA.
www.TevaPartners.com
Pharmaceutical Sales Job Search Services
Speak with a 9-year Pharmaceutical Sales veteran. We are the only job search/resume company in the U.S. that focuses only on pharmaceutical industry. Over 9,828 client successes since 1993.
www.drugrepjobsearch.com
Pharmaceutical Equipment
We help you solve your aspetic processing problems such as valves, mixers and asepconnects.
www.asepco.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo! Page
( About My Yahoo! and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?